Working with our amazing partners...
Nottingham University Hospitals (NUH) and Isla are honoured to be recognised as Health Tech News’s “ Best Health Tech Solution of the Year 2023 – Transforming Remote Diagnosis of Neurological Conditions” for their project aimed at transforming NUH’s Neurology service.
Patients can securely submit videos of their tremors and seizures for clinical review, supporting the diagnosis and treatment of conditions such as epilepsy and Dravet’s syndrome. This remarkable collaboration has garnered widespread recognition for its innovation in improving patient care.

Previously, managing Neurological conditions like epilepsy has often required patients to attend regular clinic appointments to update their clinical team on their condition’s progress. NUH, in collaboration with Isla, introduced the Isla Visual record—a web-based platform that streamlines patient-clinician communication, enabling patients, parents, family members, and carers to regularly provide updates on their condition by submitting images, videos and forms to the online platform.
Isla’s technology allows patients to submit videos of seizures or tremors and other clinical information with a simple, secure link, eliminating the need for downloads or logins. Over the past two years, more than 850 neurology patients at NUH have used Isla, submitting over 4,300 videos, photos and forms, making the process not only efficient, but also patient-centric.
This innovative approach delivers a range of benefits:
- Operational: It replaces the laborious process of manually collecting videos from patients and managing them in a shared drive.
- Clinical: Patients receive quicker diagnoses, reducing the previous six-month follow-up wait, which can prevent or reduce harm. It also results in cost savings and expedites patients’ progress to Seizure Psychology clinics.
- Information Governance: Isla enhances data security, mitigating risks associated with the transfer and storage of patient videos.
- Financial: In some cases, patients receive appropriate treatment earlier, saving time and reducing costs (clinical estimate of 4-8 week reduction in time-to-treatment). This impact can only be accurately understood over a period of years as clinical outcome data becomes available. More immediately, a clinical audit estimates that for each patient triaged a time saving of up to 5 minutes is realised.
Another saving on the avoidance of video-EEG is being realised and tracked within the team as explained by the clinical team below:
“Isla is now core to how we manage the evaluation of seizures. It prevents us from admitting some patients to hospital to perform video-EEG (costing many thousands per week). It does not remove the need entirely for video EEG but allows more selective use. It would be a disaster if we lost Isla’s functionality”
Neurology Clinical Team Tweet
The success of the Isla platform is clear, with over 7,200 patients at the Trust monitored using this technology since its launch in early 2021, 724 of which are patients treated for epilepsy. Clinical teams are adopting Isla organically due to its significant operational and patient benefits.
Isla has made a fundamental difference in outpatient epilepsy management in recent years.
Dr. Singhal, Consultant Neurologist Tweet
Patient feedback has been overwhelmingly positive, with 45 out of 46 respondents recommending the digital pathway to friends and family and rating their clinical experience at an impressive 4.54 out of 5.
This project showcases the transformative power of collaboration between clinicians and technologists in reshaping clinical pathways for the betterment of patients.
The NUH and Isla partnership shows the value of collaboration, drawing on the incredible hard work and insights of clinicians to create a technological solution that improves confidence in clinical decision-making, has efficiency and cost improvements for the Trust whilst also improving patient outcomes and quality of life.
To discuss how Isla’s comprehensive solution can help to assist your clinical pathway, get in contact using the form below and one of our friendly product experts will be in touch.
Read More

From quicker wound reviews to reduced readmissions: How technology is treating Surgical Site Infections
Surgical Site Infection (SSI) poses a significant financial burden for the NHS, estimated at a staggering £700 million annually. This not only strains the healthcare system but also results in avoidable readmissions and prolonged bed occupancy.

Target, triage, treat
Half of all cancers in England and Wales are skin cancer, with over 16,000 cases of melanoma diagnosed every year, increasing 8% annually.

More than skin deep
One in four people in England and Wales, 13.2 million, see their GP about a dermatological condition every year, with 3.5m outpatient or day surgery attendances every year